NASDAQ:AFIB • US0051111096
The current stock price of AFIB is 0.09 USD. In the past month the price decreased by -45.05%. In the past year, price decreased by -89.69%.
ChartMill assigns a fundamental rating of 2 / 10 to AFIB. AFIB may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AFIB reported a non-GAAP Earnings per Share(EPS) of -2.69. The EPS increased by 34.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -111.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
6 analysts have analysed AFIB and the average price target is 1.53 USD. This implies a price increase of 1600% is expected in the next year compared to the current price of 0.09.
For the next year, analysts expect an EPS growth of 12.16% and a revenue growth 31.1% for AFIB
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.51 | 195.206B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.27 | 175.203B | ||
| SYK | STRYKER CORP | 24.36 | 141.182B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.51 | 113.14B | ||
| BDX | BECTON DICKINSON AND CO | 11.39 | 50.537B | ||
| IDXX | IDEXX LABORATORIES INC | 42.32 | 50B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.31 | 45.525B | ||
| RMD | RESMED INC | 21 | 37.268B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.3 | 37.194B | ||
| DXCM | DEXCOM INC | 28.56 | 27.469B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 225 full-time employees. The company went IPO on 2020-08-06. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The firm's product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.
ACUTUS MEDICAL INC
2210 Faraday Ave Ste 100
Carlsbad CALIFORNIA 92008 US
CEO: Vince Burgess
Employees: 225
Phone: 14422326144
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 225 full-time employees. The company went IPO on 2020-08-06. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The firm's product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.
The current stock price of AFIB is 0.09 USD. The price decreased by -26.83% in the last trading session.
AFIB does not pay a dividend.
AFIB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
ACUTUS MEDICAL INC (AFIB) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
ACUTUS MEDICAL INC (AFIB) has a market capitalization of 2.67M USD. This makes AFIB a Nano Cap stock.